A Phase 2 biomarkerdriven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultrarare cancer with a highly lifethreatening unmet medical needs(NCCH1806/MK004)
Milademetan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 2 biomarkerdriven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultrarare cancer with a highly lifethreatening unmet medical needs(NCCH1806/MK004) ### Output: Milademetan